Investors

Beta Bionics is a for-profit, public benefit corporation and Certified B Corporation

Since founding Beta Bionics in 2015, our mission has been to help improve health outcomes and the quality of life of all children and adults living with diabetes and other conditions of glycemic dysregulation.

FAQs

Beta Bionics is not currently seeking private investment and does not broadly solicit individual investment.

Beta Bionics is a private, for profit, public benefit corporation. If you are seeking to make a donation, we suggest donating to a non-profit organization that supports the type 1 diabetes community.

We are working very hard at Beta Bionics to bring our technology through regulatory approval to people with type 1 diabetes. You can follow our development work on our web site and via social media.

Privately held shares in Beta Bionics are not liquid or tradeable on any public stock exchange at this time. Additionally, Beta Bionics shares are not tradeable privately at this time. While this may change in the future, there are no currently available avenues through which to liquidate an investment in Beta Bionics.

At this time, there are no Beta Bionics shares available for purchase on any stock exchange or by any private means. We are very pleased to have strong institutional investor support to complement our 2016 Reg CF investor community. While the Reg CF was a fundraising strategy the company utilized early on, we do not foresee any future share offerings via Regulation Crowdfunding.

RESOURCES

Annual reg CF reports.

Part of our open culture is the publication of our annual reports.
So here they are. Just select the one you want to see and click to download your copy.

Reg CF
Report
2021

Reg CF
Report
2020

Reg CF
Report
2019

Reg CF
Report
2018

Reg CF
Report
2017

Reg CF
Report
2016

Not What
you’re
looking for?